Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03870048 · ClinicalTrials.gov registry record · NA
tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03870048 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 6 participants.
The verdict
NCT03870048, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) on neuropathic pain and fatigue in people with MS. The investigators will conduct tDCS or sham on 5 consecutive days. They will evaluate pain and fatigue with specific questionnaires and measure fatigability with an isokinetic device. The research question is whether tDCS can lessen neuropathic pain and increase fatigue resistance in people with MS. It is hypothesized, that less neuropathic pain and increased fatigue resistance after the tDCS sessions.
Interventions
- DEVICE transcranial direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03870048
The ClinicalTrials.gov registry entry for NCT03870048 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transcranial direct current stimulation is the first listed.
NCT03870048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03870048 about?
NCT03870048 is a clinical study titled "tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis". The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) on neuropathic pain and fatigue in people with MS. The investigators will conduct tDCS or sham on 5 consecutive days. They will evaluate pain and fatigue with specific questionnaires and measure...
What is the current status of trial NCT03870048?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-04-15. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03870048?
The interventions under investigation include: transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT03870048?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.